手术上更换大动脉膜的新技术和技术:一个大型回顾性队列分析
Vincenzo Caruso1, Rajdeep Bilkhu1, Christopher Young1
1Cardiovascular Department, St. Thomas' Hospital, London SE1 7EH, UK.
Journal of clinical medicine
|July 27, 2024
概括
手术性大动脉置换 (SAVR) 显示出优异的生存率和较低的并发症率,即使在高风险患者中也是如此. 假肢和技术的进步进一步改善了大动脉狭窄的结果.
科学领域:
- 心血管外科心血管外科
- 心脏门手术 心脏门手术
- 大动脉狭窄症 大动脉狭窄症
背景情况:
- 穿门植入 (TAVI) 越来越多地用于大动脉狭窄.
- 手术大动脉置换 (SAVR) 的结果需要在不同的风险类别中进行评估.
- 这项研究评估了SAVR与TAVI在各种患者风险概况中的性能.
研究的目的:
- 评估手术上大动脉置换 (SAVR) 的短期和长期结果.
- 在不同患者风险类别中比较SAVR性能.
- 分析与SAVR相关的死亡率和并发症率.
主要方法:
- 在单个中心进行前性,观察性队列研究.
- 包括1501名接受隔离性大动脉置换 (生物,机械,同种植,罗斯手术) 的患者.
- 从内部数据库收集的数据;主要终点是手术后和晚期死亡率;次要终点是术后并发症.
主要成果:
- 住院死亡率为1%;60个月生存率为98.7%.
- 手术紧急和心脏性休克预测死亡率.
- 罗斯手术组比较年轻,并发症较少,所有人都经过了随访.
结论:
- SAVR提供了很好的生存率和较低的并发症率,即使手术风险增加.
- 技术进步,如无假肢和最少的侵入性方法,提高了SAVR的结果.
- SAVR仍然是对大动脉狭窄的可行和有效治疗方法.
相关概念视频
Mitral Stenosis III: Medical Management
483
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
483
Aortic Regurgitation III: Medical Management
562
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
562


